12,852 resources
Start Prev Rows 6800 - 7000 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1099 | Specific Infection Syndrome (BT) | active | 2008-01 | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1091 | Gastrointestinal Syndrome (BT) | active | 2008-01 | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1097 | Respiratory Syndrome (BT) | active | 2008-01 | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1095 | Neurological Syndrome (BT) | active | 2008-01 | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1098 | Severe Illness Or Death Syndrome (BT) | active | 2008-01 | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1090 | Fever Syndrome (BT) | active | 2008-01 | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1094 | Lymphadenitis Syndrome (BT) | active | 2008-01 | fhir | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7702 | ATI Method (RIBD) | active | 2018-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3343 | Abnormal Flag (HL7 27) | active | 2010-01 | oid | |||
| hl7.fhir.us.breast-radiology | R4 | rde1556-presence | RDE1556 Presence | draft | 2022-12 | hl7 | fhir | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.34 | AbnormalityOfGaitAndMobility | active | 2021-07 | hl7 | icd | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3344 | Accept Application Acknowledgment Conditions (HL7) | active | 2017-01 | tho | |||
| hl7.fhir.us.mcode | R4 | mcode-tumor-size-units-vs | Tumor Size Units Value Set | active | 3 | cic | 2025-02 | hl7 | ucum |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.958 | Acknowledgment Code (HL7) | active | 2008-01 | tho | |||
| signal.core.r4 | R4 | questionnaire-ccars-action-types | Questionnaire CCARS Action Types | draft | 1 | pa | hl7 | ||
| fhir.cqf.common | R4 | active-condition | CQF Active Condition | active | 2019-07 | hl7 | tho | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8014 | Activity Type Anthrax | active | 2020-01 | tho oid | |||
| hl7.fhir.us.vrdr | R4 | vrdr-activity-at-time-of-death-vs | Activity at Time of Death ValueSet | active | pher | 2024-10 | hl7 | fhir tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3102 | Skin Exposure Activity (FDD) | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8011 | Activity Type (Leptospirosis) | active | 2020-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7985 | Actual Route of Administration (Anthrax) | active | 2020-01 | sct tho | |||
| hl7.fhir.us.nhsn-dqm | R4 | ach-encounter-class | Acute Care Hospital Encounter Class ValueSet | trial-use | 1 | pher | 2025-07 | hl7 | tho |
| hl7.fhir.us.nhsn-dqm | R4 | ach-encounter-status | Acute Care Hospital Encounter Status ValueSet | trial-use | 1 | pher | 2025-07 | hl7 | fhir |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3213 | Signs and Symptoms (Acute Hepatitis B) | active | 2009-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3206 | Lab Test Result Name (Acute Hepatitis B) | active | 2009-01 | loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3221 | Disease Type (Acute Hepatitis B) | active | 2009-01 | sct | |||
| us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.10416 | Financially Responsible Party Type Value Set | active | 2024-06 | hl7 | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.20 | Telecom Use (US Realm Header) | active | 2024-06 | hl7 | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.19579 | Family Member Value | active | 2024-06 | hl7 | tho | ||
| us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.38 | Smoking Status | active | 2024-06 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3162 | Risk Factors (TB) | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.801 | Address Type (HL7) | active | 2018-01 | tho | |||
| hl7.fhir.us.davinci-crd | R4 | locationAddressType | CRD Location Address Types Value Set | trial-use | 3 | fm | 2025-07 | hl7 | fhir |
| hl7.fhir.us.davinci-hrex | R4 | hrex-coverage-relationship | HRex Coverage Relationship ValueSet | draft | 0 | cic | 2025-04 | hl7 | fhir tho |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.313 | Statin Allergen Grouping | active | 2024-03 | hl7 | vsac | ||
| us.cdc.phinvads | R4 | 2.16.840.1.113883.1.11.1 | Administrative Gender (HL7 V3) | active | 2019-01 | tho | |||
| fhir.kisumuhie | R4 | gender-vs | Gender | draft | 2025-06 | hl7 | |||
| fhir.kenyaPSIG | R4 | administrative-gender-vs | Administrative Gender | active | 2025-07 | hl7 | fhir | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.645 | Pneumococcal Vaccine HD_CN_ Allergy | active | 2025-04 | hl7 | sct | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.638 | b.well Adult Tetanus Vaccine CN | active | 2025-04 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.648 | bwell COVID Vaccine CN_Met | active | 2025-04 | hl7 | vsac | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7758 | Adverse Event Severity (TB) | active | 2017-12 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.963 | Consequence of Adverse Event | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7596 | Adverse Event Severity (Malaria) | active | 2019-01 | sct tho oid | |||
| fhir.acme.affiliate-report | R4 | affiliate-type-vs | Affiliate Type ValueSet | draft | 2025-05 | hl7 | internal | ||
| hl7.fhir.us.registry-protocols | R4 | YesNo | Yes or No | active | cic | 2023-11 | hl7 | sct tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3065 | Age Category (Animal) | active | 2008-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3259 | Age Group (Flu) | active | 2009-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7905 | Age units (ARLN) | active | 2019-01 | ucum | |||
| hl7.fhir.us.davinci-pdex | R4 | ProvenanceAgentType | Provenance Agent Type | informative | fm | 2025-06 | hl7 | fhir tho | |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8054 | Alanine aminotransferase (ALT) Result (Hepatitis) | active | 2021-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8019 | Alcohol Use Frequency (Anthrax) | active | 2020-01 | sct tho oid | |||
| hl7.fhir.us.registry-protocols | R4 | StressTest | Cath PCI Selected Stress Test | active | cic | 2023-11 | hl7 | loinc | |
| fhir.cdc.opioid-cds-r4 | R4 | barbiturate-medications | Barbiturate Medications | active | 2025-02 | hl7 | |||
| fhir.cdc.opioid-cds-r4 | R4 | buprenorphine-and-methadone-medications | Buprenorphine and Methadone medications | active | 2023-05 | hl7 | |||
| fhir.cdc.opioid-cds-r4 | R4 | buprenorphine-medications | Buprenorphine Medications | active | 2025-02 | hl7 | |||
| fhir.dicom | R4 | all | All DICOM Controlled Terminology Definitions | active | 2025-04 | hl7 | dcm | ||
| hl7.fhir.us.icsr-ae-reporting | R4 | ISBTConvalescentPlasmaCodeVS | ISBT Convalescent Plasma Codes | draft | 2023-08 | hl7 | |||
| hl7.fhir.us.icsr-ae-reporting | R4 | ISBTBloodProductCodeVS | ISBT Blood Product Codes | draft | 2023-08 | hl7 | |||
| hl7.fhir.us.registry-protocols | R4 | SEattleAnginaQs | Seattle Angina Questions | active | cic | 2023-11 | hl7 | loinc | |
| fhir.tx.support.r4 | R4 | covid-19-obs | COVID-19 related Observation codes | draft | 2020-03 | hl7 | loinc | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1267.13 | Screening and Assessment Survey Codes | active | 2024-10 | hl7 | loinc | ||
| fhir.argonaut.r2 | R2 | substance-ndfrt | DAF Substance ND-FRT codes | draft | 2016-10 | hl7 | fhir | ||
| fhir.cdc.opioid-cds-r4 | R4 | oxycodone-medications | Oxycodone Medications | active | 2025-02 | hl7 | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6053 | Lab Test Name (Reportable Conditions) | active | 2017-01 | loinc | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6054 | Lab Test Result (Reportable Conditions) | active | 2016-01 | sct | |||
| fhir.argonaut.r2 | R2 | substance-rxnorm | DAF Substance RxNorm Codes | draft | 2016-10 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1190.58 | Diabetes Medications | active | 2022-03 | hl7 | rx | ||
| fhir.tx.support.r4 | R4 | covid-19-cond | COVID-19 related Condition codes | draft | 2020-03 | hl7 | sct | ||
| hl7.fhir.us.registry-protocols | R4 | HemodialysisOrPeritonealDialysis | hemodialysis or peritoneal dialysis | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | CardiacArrest | Cardiac Arrest | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | CABG | Coronary artery bypass grafting | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | CerebrovascularDisease | Cerebrovascular Disease | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | PeripheralArterialOcclusiveDisease | Peripheral Arterial Occlusive Disease | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | DiabetesMellitus | Diabetes Mellitus | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | Dyslipidemia | Dyslipidemia | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | HeartFailure | Heart Failure codes from SNOMED | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | Hypertension | Hypertension | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | PercutaneousCoronaryIntervention | PCI | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | PriorCABG | Prior History of Coronary Artery Bypass Graft | active | cic | 2023-11 | hl7 | sct loinc | |
| hl7.fhir.us.registry-protocols | R4 | HypothermiaInduced | Induced Hypothermia Codes | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | OrganDonor | SNOMED Valueset of Organ Donor codes | active | cic | 2023-11 | hl7 | sct | |
| hl7.fhir.us.registry-protocols | R4 | AbnormalElectrocardiacAssessment | Abnormal Electrocardiac Assessment | active | cic | 2023-11 | hl7 | sct | |
| fhir.cdc.opioid-cds-r4 | R4 | benzodiazepine-medications | Benzodiazepine medications | active | 2025-02 | hl7 | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.230 | All Cancer Directed therapies | active | 2024-05 | hl7 | rx | ||
| hl7.fhir.us.registry-protocols | R4 | FamilyPrematureCAD | Family History of Premature CAD | active | cic | 2023-11 | hl7 | sct loinc | |
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.158 | Multiple Myeloma Regimen Drugs | active | 2019-08 | hl7 | rx | ||
| fhir.cdc.opioid-cds-r4 | R4 | naloxone-medications | Naloxone medications | active | 2025-02 | hl7 | |||
| fhir.cdc.opioid-cds-r4 | R4 | cdc-malignant-cancer-conditions | CDC malignant cancer conditions | active | 2023-05 | hl7 | icd | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.226 | Opioids, All | active | 2024-01 | hl7 | rx | ||
| fhir.cdc.opioid-cds-r4 | R4 | opioid-analgesics-with-ambulatory-misuse-potential | Opioid analgesics with ambulatory misuse potential | active | 2025-02 | hl7 | |||
| fhir.cdc.opioid-cds-r4 | R4 | extended-release-opioid-with-ambulatory-misuse-potential | Extended release opioid with ambulatory misuse potential | active | 2025-02 | hl7 | |||
| fhir.argonaut.r2 | R2 | medication-codes | Medication Clinical Drug (RxNorm) | draft | 2016-05 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1053 | Carbidopa Levodopa Combination (RXNORM) | active | 2025-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2362 | Tuberculosis (Ethambutol) (RXNORM) | active | 2024-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2363 | Tuberculosis (Isoniazid [INH]) (RXNORM) | active | 2024-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2364 | Tuberculosis (Pyrazinamide [PZA]) (RXNORM) | active | 2024-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2365 | Tuberculosis (Rifabutin) (RXNORM) | active | 2024-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2366 | Tuberculosis (Rifampin) (RXNORM) | active | 2024-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2367 | Tuberculosis (Rifapentine) (RXNORM) | active | 2024-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.741 | Hepatitis B Immune Globulin (RXNORM) | active | 2023-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.747 | Penicillin G [Benzathine] [Injectable] [Bicillin] (RXNORM) | active | 2025-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.844 | Tuberculosis (Second Line Drugs for Treatment) (RXNORM) | active | 2024-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.991 | Rifampin (RXNORM) | active | 2024-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1594 | HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM) | active | 2023-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1595 | HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM) | active | 2023-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1597 | HIV Infection (ARV Combination Treatment for HIV) (RXNORM) | active | 2023-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1598 | HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM) | active | 2023-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1600 | HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM) | active | 2023-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1634 | Sofosbuvir Velpatasvir Combination (RXNORM) | active | 2023-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1912 | Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM) | active | 2023-01 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1913 | Penicillin G [Procaine] [Injectable] (RXNORM) | active | 2025-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1078 | Opioid Overdose and Poisoning (Naloxone) (RxNorm) | active | 2025-02 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1618 | Smallpox Vaccine (RXNORM) | active | 2023-06 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2142 | Linezolid (RXNORM) | active | 2023-01 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2143 | Tuberculosis (Pretomanid) (RXNORM) | active | 2023-01 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.2144 | Tuberculosis (Bedaquiline) (RXNORM) | active | 2023-01 | hl7 | rx | ||
| hl7.fhir.us.davinci-crd | R4 | configTypes | CRD Configuration Code Data Types Value Set | trial-use | 3 | fm | 2025-07 | hl7 | fhir |
| hl7.fhir.us.mcode | R4 | mcode-brachytherapy-high-dose-rate-technique-vs | Brachytherapy High Dose Rate Technique Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-brachytherapy-high-dose-rate-electronic-technique-vs | Brachytherapy High Dose Rate Electronic Technique Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-brachytherapy-low-dose-rate-temporary-technique-vs | Brachytherapy Low Dose Rate Temporary Radiation Technique Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-brachytherapy-pulsed-dose-rate-technique-vs | Brachytherapy Pulsed Dose Rate Technique Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-brachytherapy-permanent-seeds-technique-vs | Brachytherapy Permanent Seeds Technique Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-brachytherapy-radiopharmaceutical-technique-vs | Brachytherapy Radiopharmaceutical Technique Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-carbon-ion-beam-technique-vs | Carbon Ion Beam Technique Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-electron-beam-technique-vs | Electron Beam Technique Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-neutron-beam-technique-vs | Neutron Beam Technique Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-photon-beam-technique-vs | Photon Beam Technique Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| hl7.fhir.us.mcode | R4 | mcode-teleradiotherapy-proton-beam-technique-vs | Proton Beam Technique Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6037 | Industry (Census) | active | 2012-01 | oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.16 | Reasons for Interventions Related to Medication Management | active | 2022-03 | hl7 | vsac | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1026 | Pregnancy Trimester | active | 2008-01 | sct tho | |||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.558 | Butalbital analgesics | active | 2023-08 | hl7 | rx | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.789 | Social Determinants of Health Procedures | active | 2024-12 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.790 | Social Determinants of Health Service Requests | active | 2024-12 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.11 | Food Insecurity Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.118 | Health Literacy Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.119 | Health Literacy Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.122 | Medical Cost Burden Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.123 | Medical Cost Burden Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.124 | Health Insurance Coverage Status Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.125 | Health Insurance Coverage Status Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.20 | Homelessness Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.21 | Homelessness Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.226 | Digital Literacy Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.227 | Digital Literacy Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.235 | Digital Access Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.236 | Digital Access Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.247 | Utility Insecurity Procedures | active | 2024-05 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.252 | Utility Insecurity Service Requests | active | 2024-05 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.260 | Incarceration Status Procedures | active | 2024-12 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.261 | Incarceration Status Service Requests | active | 2024-12 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.268 | Language Access Procedures | active | 2024-12 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.269 | Language Access Service Requests | active | 2024-12 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.27 | Transportation Insecurity Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.28 | Transportation Insecurity Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.31 | Financial Insecurity Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.32 | Financial Insecurity Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.38 | Material Hardship Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.39 | Material Hardship Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.44 | Housing Instability Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.45 | Housing Instability Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.52 | Inadequate Housing Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.53 | Inadequate Housing Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.56 | Less Than High School Education Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.57 | Less Than High School Education Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.59 | Unemployment Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.60 | Unemployment Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.67 | Elder Abuse Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.68 | Elder Abuse Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.7 | Food Insecurity Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.87 | Stress Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.90 | Veteran Status Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.91 | Veteran Status Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.92 | Stress Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.94 | Social Connection Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.95 | Social Connection Service Requests | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.97 | Intimate Partner Violence Procedures | active | 2024-06 | hl7 | vsac | ||
| us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1247.98 | Intimate Partner Violence Service Requests | active | 2024-06 | hl7 | vsac | ||
| fhir.cdc.opioid-cds-r4 | R4 | amphetamines-class-medications | Amphetamine class medications | active | 2025-02 | hl7 | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.965 | Amplification and Extraction Kit | active | 2008-01 | oid | |||
| hl7.fhir.us.covid19library | R4 | covid-19-severity-value-set | COVID-19 Signs and Symptoms Severity Value Set | active | 2022-07 | hl7 | sct | ||
| hl7.fhir.us.breastcancer | R3 | oncology-TumorMarginDescriptionVS | BC TumorMarginDescriptionVS ValueSet | draft | 2018-08 | hl7 | sct | ||
| hl7.fhir.us.breastcancer | R3 | oncology-Ki-67NuclearAntigenVS | BC Ki-67NuclearAntigenVS ValueSet | draft | 2018-08 | hl7 | sct | ||
| signal.core.r4 | R4 | servicerequest-orderdetail | Service Request Order Details Codes | draft | 1 | oo | 2019-10 | hl7 | sct |
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7613 | Job Supervisory Level or Pay Grade (ODH) | active | 2020-01 | tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7652 | Mailing Address Indicator (NCHS) | active | 2017-01 | oid | |||
| us.nlm.vsac | R4 | 2.16.840.1.113883.10.20.22.5.306 | Infectious Disease | active | 2024-06 | hl7 | sct | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3124 | Body Region (Tetanus) | active | 2008-01 | sct oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7189 | Specimen Source (STD) | active | 2020-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7554 | Specimen Collection Site AST (STD) | active | 2017-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3285 | Anatomical Entity (Body Site) | active | 2009-01 | sct | |||
| hl7.fhir.us.breastcancer | R3 | cimi-element-AnatomicalDirectionVS | BC AnatomicalDirectionVS ValueSet | draft | 2018-08 | hl7 | fhir | ||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1074 | Animal | active | 2010-01 | sct | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3072 | Animal Type (FDD) | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7793 | Likely Contact (Listeria) | active | 2018-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3067 | Virus Variant Type (Animal Rabies) | active | 2008-01 | tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3068 | Animal Species (Animal Rabies) | active | 2008-01 | sct tho oid | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7971 | Animal Type (Brucellosis) | active | 2020-01 | sct tho | |||
| us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7967 | Animal Type (Leptospirosis) | active | 2020-01 | sct tho |
FHIR